시장보고서
상품코드
1090861

세계의 이식형 의료기기 시장 - 기회 분석과 산업 예측(2020-2030년) : 제품별(정형외과 임플란트, 심장혈관 임플란트, 안내 렌즈, 치과 임플란트, 유방 임플란트, 기타)

Implantable Medical Devices Market By Product (Orthopedic Implants, Cardiovascular Implants , Intraocular Lens , Dental Implants, Breast Implants, Other Implants), : Global Opportunity Analysis and Industry Forecast, 2020-2030

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 225 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 이식형 의료기기 시장 규모는 2020년 918억 6,894만 달러에서 예측 기간에는 7.2%의 연평균 복합 성장률(CAGR)로 확대되어 2030년에는 1,790억 3,275만 달러 규모로 성장할 것으로 예측됩니다.

급속한 고령화에 따른 만성질환 증가가 시장 성장을 가속하고 있습니다. 이식형 의료기기의 인지도 향상과 기술적 발전 시장 성장에 기여하고 있습니다. 한편, 높은 비용, 전문가 부족이 시장 성장의 주요 장벽이 되고 있습니다. 상환 정책 급증은 예측 기간에 시장 확대를 위한 유리한 기회가 될 전망입니다.

세계의 이식형 의료기기(Implantable Medical Devices) 시장을 조사했으며, 시장의 정의와 개요, 각종 시장 성장 영향요인 분석, 시장 규모 추이와 예측, 각종 구분·지역/주요 국가별 분석, 경쟁 환경, 주요 기업 프로파일 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 개요

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
  • Porter의 산업 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • COVID-19 : 영향 분석

제4장 이식형 의료기기 시장 : 제품별

  • 개요
  • 정형외과 임플란트
  • 심장혈관 임플란트
  • 안내 렌즈
  • 치과 임플란트
  • 유방확대수술
  • 기타
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모와 예측 : 지역별
    • 시장 분석 : 국가별

제5장 이식형 의료기기 시장 : 지역별

  • 개요
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카, 중동 및 아프리카

제6장 기업 상황

  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경쟁 히트맵
  • 주요 전개

제7장 기업 개요

  • Abbott Laboratories
  • Biotronik SE and Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • CONMED Corporation
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson and Johnson
  • LivaNova PLC
LSH 22.06.30

The global implantable medical devices market was valued at $91,868.94 million in 2020, and is projected to reach $179,032.75 million by 2030, registering a CAGR of 7.2% from 2021 to 2030. Implantable medical devices are surgically transplanted inside the body. These implants are used to replace or support any damaged body organ to enhance function of any body organ or to detect errors in normal body functioning. These devices can be either placed permanently or temporarily in human body and can be removed when they are no longer needed. These implantable devices are made up of bone, tissue, skin, ceramics, metals, and other natural materials.

The rise in prevalence of chronic diseases coupled with the rapidly ageing population drives the growth of the market. Moreover, increased awareness and technological advancements in medical implants also contributes toward the growth of the market. However, high implantation cost and lack of trained professionals in the medical surgeries sector are the major barriers for the growth of the market. Conversely, the surge in number of the reimbursement policies is expected to offer lucrative opportunities for market expansion during the forecast period. 

The implantable medical devices market is segmented on the basis of product and region. By product, the market is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses and other implants. The orthopedic implants are further classified as spinal implants and reconstructive joint replacements. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the implantable medical devices market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Key Market Segments

By BY PRODUCT

  • Breast Implants
  • Other Implants
  • Orthopedic Implants
  • Cardiovascular Implants
  • Intraocular Lens
  • Dental Implants

By BY REGION

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Abbott Laboratories
    • Biotronik SE and Co. KG
    • Boston Scientific Corporation
    • C. R. Bard, Inc.
    • Cardinal Health, Inc.
    • CONMED Corporation
    • Globus Medical, Inc.
    • Integra LifeSciences Holdings Corporation
    • Johnson and Johnson
    • LivaNova PLC

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Orthopedic Implants
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Cardiovascular Implants 
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Intraocular Lens 
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Dental Implants
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Breast Implants
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country
  • 4.7 Other Implants
    • 4.7.1 Key market trends, growth factors and opportunities
    • 4.7.2 Market size and forecast, by region
    • 4.7.3 Market analysis by country

CHAPTER 5: IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 North America
    • 5.2.1 Key trends and opportunities
    • 5.2.2 North America Market size and forecast, by Product
    • 5.2.3 North America Market size and forecast, by country
      • 5.2.3.1 U.S.
      • 5.2.3.1.1 Market size and forecast, by Product
      • 5.2.3.2 Canada
      • 5.2.3.2.1 Market size and forecast, by Product
      • 5.2.3.3 Mexico
      • 5.2.3.3.1 Market size and forecast, by Product
  • 5.3 Europe
    • 5.3.1 Key trends and opportunities
    • 5.3.2 Europe Market size and forecast, by Product
    • 5.3.3 Europe Market size and forecast, by country
      • 5.3.3.1 Germany
      • 5.3.3.1.1 Market size and forecast, by Product
      • 5.3.3.2 France
      • 5.3.3.2.1 Market size and forecast, by Product
      • 5.3.3.3 United Kingdom
      • 5.3.3.3.1 Market size and forecast, by Product
      • 5.3.3.4 Italy
      • 5.3.3.4.1 Market size and forecast, by Product
      • 5.3.3.5 Spain
      • 5.3.3.5.1 Market size and forecast, by Product
      • 5.3.3.6 Rest of Europe
      • 5.3.3.6.1 Market size and forecast, by Product
  • 5.4 Asia-Pacific
    • 5.4.1 Key trends and opportunities
    • 5.4.2 Asia-Pacific Market size and forecast, by Product
    • 5.4.3 Asia-Pacific Market size and forecast, by country
      • 5.4.3.1 Japan
      • 5.4.3.1.1 Market size and forecast, by Product
      • 5.4.3.2 China
      • 5.4.3.2.1 Market size and forecast, by Product
      • 5.4.3.3 Australia
      • 5.4.3.3.1 Market size and forecast, by Product
      • 5.4.3.4 India
      • 5.4.3.4.1 Market size and forecast, by Product
      • 5.4.3.5 South Korea
      • 5.4.3.5.1 Market size and forecast, by Product
      • 5.4.3.6 Rest of Asia-Pacific
      • 5.4.3.6.1 Market size and forecast, by Product
  • 5.5 LAMEA
    • 5.5.1 Key trends and opportunities
    • 5.5.2 LAMEA Market size and forecast, by Product
    • 5.5.3 LAMEA Market size and forecast, by country
      • 5.5.3.1 Brazil
      • 5.5.3.1.1 Market size and forecast, by Product
      • 5.5.3.2 Saudi Arabia
      • 5.5.3.2.1 Market size and forecast, by Product
      • 5.5.3.3 South Africa
      • 5.5.3.3.1 Market size and forecast, by Product
      • 5.5.3.4 Rest of LAMEA
      • 5.5.3.4.1 Market size and forecast, by Product

CHAPTER 6: COMPANY LANDSCAPE

  • 6.1. Introduction
  • 6.2. Top winning strategies
  • 6.3. Product Mapping of Top 10 Player
  • 6.4. Competitive Dashboard
  • 6.5. Competitive Heatmap
  • 6.6. Key developments

CHAPTER 7: COMPANY PROFILES

  • 7.1 Abbott Laboratories
    • 7.1.1 Company overview
    • 7.1.2 Company snapshot
    • 7.1.3 Operating business segments
    • 7.1.4 Product portfolio
    • 7.1.5 Business performance
    • 7.1.6 Key strategic moves and developments
  • 7.2 Biotronik SE and Co. KG
    • 7.2.1 Company overview
    • 7.2.2 Company snapshot
    • 7.2.3 Operating business segments
    • 7.2.4 Product portfolio
    • 7.2.5 Business performance
    • 7.2.6 Key strategic moves and developments
  • 7.3 Boston Scientific Corporation
    • 7.3.1 Company overview
    • 7.3.2 Company snapshot
    • 7.3.3 Operating business segments
    • 7.3.4 Product portfolio
    • 7.3.5 Business performance
    • 7.3.6 Key strategic moves and developments
  • 7.4 C. R. Bard, Inc.
    • 7.4.1 Company overview
    • 7.4.2 Company snapshot
    • 7.4.3 Operating business segments
    • 7.4.4 Product portfolio
    • 7.4.5 Business performance
    • 7.4.6 Key strategic moves and developments
  • 7.5 Cardinal Health, Inc.
    • 7.5.1 Company overview
    • 7.5.2 Company snapshot
    • 7.5.3 Operating business segments
    • 7.5.4 Product portfolio
    • 7.5.5 Business performance
    • 7.5.6 Key strategic moves and developments
  • 7.6 CONMED Corporation
    • 7.6.1 Company overview
    • 7.6.2 Company snapshot
    • 7.6.3 Operating business segments
    • 7.6.4 Product portfolio
    • 7.6.5 Business performance
    • 7.6.6 Key strategic moves and developments
  • 7.7 Globus Medical, Inc.
    • 7.7.1 Company overview
    • 7.7.2 Company snapshot
    • 7.7.3 Operating business segments
    • 7.7.4 Product portfolio
    • 7.7.5 Business performance
    • 7.7.6 Key strategic moves and developments
  • 7.8 Integra LifeSciences Holdings Corporation
    • 7.8.1 Company overview
    • 7.8.2 Company snapshot
    • 7.8.3 Operating business segments
    • 7.8.4 Product portfolio
    • 7.8.5 Business performance
    • 7.8.6 Key strategic moves and developments
  • 7.9 Johnson and Johnson
    • 7.9.1 Company overview
    • 7.9.2 Company snapshot
    • 7.9.3 Operating business segments
    • 7.9.4 Product portfolio
    • 7.9.5 Business performance
    • 7.9.6 Key strategic moves and developments
  • 7.10 LivaNova PLC
    • 7.10.1 Company overview
    • 7.10.2 Company snapshot
    • 7.10.3 Operating business segments
    • 7.10.4 Product portfolio
    • 7.10.5 Business performance
    • 7.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제